Literature DB >> 11206376

Use of 13C NMR spectrometric data to produce a predictive model of estrogen receptor binding activity.

R D Beger1, J P Freeman, J O Lay, J G Wilkes, D W Miller.   

Abstract

We have developed a spectroscopic data-activity relationship (SDAR) model based on 13C NMR spectral data for 30 estrogenic chemicals whose relative binding affinities (RBA) are available for the alpha (ERalpha) and beta (ERbeta) estrogen receptors. The SDAR models segregated the 30 compounds into strong and medium binding affinities. The SDAR model gave a leave-one-out (LOO) cross-validation of 90%. Two compounds that were classified incorrectly in the SDAR model were in the transition zone between classifications. Real and predicted 13C NMR chemical shifts were used with test compounds to evaluate the predictive behavior of the SDAR model. The 13C NMR SDAR model using predicted 13C NMR data for the test compounds provides a rapid, reliable, and simple way to screen whether a compound binds to the estrogen receptors.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11206376     DOI: 10.1021/ci0000878

Source DB:  PubMed          Journal:  J Chem Inf Comput Sci        ISSN: 0095-2338


  2 in total

1.  Modeling chemical interaction profiles: I. Spectral data-activity relationship and structure-activity relationship models for inhibitors and non-inhibitors of cytochrome P450 CYP3A4 and CYP2D6 isozymes.

Authors:  Brooks McPhail; Yunfeng Tie; Huixiao Hong; Bruce A Pearce; Laura K Schnackenberg; Weigong Ge; Luis G Valerio; James C Fuscoe; Weida Tong; Dan A Buzatu; Jon G Wilkes; Bruce A Fowler; Eugene Demchuk; Richard D Beger
Journal:  Molecules       Date:  2012-03-15       Impact factor: 4.411

2.  Synthesis, Antibacterial Evaluation and QSAR of α-Substituted-N₄-Acetamides of Ciprofloxacin and Norfloxacin.

Authors:  Amjad M Qandil; Lorca O Al-Zoubi; Amal G Al-Bakri; Haneen A Amawi; Qosay A Al-Balas; Abdulmalik M Alkatheri; Abdulkareem M Albekairy
Journal:  Antibiotics (Basel)       Date:  2014-06-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.